Anixa Biosciences
Biotechnology, San Jose, California, 90025, United States, 1-10 Employees
Phone Number: 40********
Who is ANIXA BIOSCIENCES
Anixa Biosciences (NASDAQ:ANIX) is a clinical stage biotechnology company focused on the treatment and prevention of cancer. Anixa's therapeutic portfolio consists of an ovarian cancer im...
Read More
-
Headquarters: San Jose, California, 90025, United States
-
Date Founded: 1982
-
Employees: 1-10
-
Revenue: Under $1 Million
-
Active Tech Stack: See technologies
-
CEO:
Amit Kumar
Email
Phone
Industry: Biotechnology
SIC Code: 7382
|
NAICS Code: 561621 |
Show More
Does something look wrong? Fix it. | View contact records from ANIXA BIOSCIENCES
Anixa Biosciences Org Chart and Mapping
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding Anixa Biosciences
Answer: Anixa Biosciences's headquarters are located at San Jose, California, 90025, United States
Answer: Anixa Biosciences's phone number is 40********
Answer: Anixa Biosciences's official website is https://anixa.com
Answer: Anixa Biosciences's revenue is Under $1 Million
Answer: Anixa Biosciences's SIC: 7382
Answer: Anixa Biosciences's NAICS: 561621
Answer: Anixa Biosciences has 1-10 employees
Answer: Anixa Biosciences is in Biotechnology
Answer: Anixa Biosciences contact info: Phone number: 40******** Website: https://anixa.com
Answer: Anixa Biosciences (NASDAQ:ANIX) is a clinical stage biotechnology company focused on the treatment and prevention of cancer. Anixa's therapeutic portfolio consists of an ovarian cancer immunotherapy program being developed in collaboration with Moffitt Cancer Center, which uses a novel type of CAR-T, known as chimeric endocrine receptor T-cell (CER-T) technology. The companys vaccine portfolio includes a novel vaccine being developed in collaboration with Cleveland Clinic to prevent breast cancer--specifically triple negative breast cancer (TNBC), the most lethal form of the disease--as well as a vaccine to prevent ovarian cancer. These vaccine technologies focus on immunizing against "retired" proteins that have been found to be expressed in certain forms of cancer. Anixa's unique business model of partnering with world-renowned research institutions on clinical development allows the company to continually examine emerging technologies in complementary fields for further development and commercialization.
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Get Full Access
Sign in to CIENCE GO Data to uncover contact details
Free credits every month